STIs, explained simply

Germs travel between people. Sex is one of the roads.

A sexually transmitted infection is a tiny living thing that used sex to reach a new home. This guide shows how each one moves, how likely it is to pass, what clears it, and what happens if you wait.

Germs on a lab slide A round microscope view. Amber rods and budding yeast are residents. Violet paired dots and corkscrews are travelling bacteria. Pink hexagons are viruses. Green pear-shaped cells are parasites.
Drawn like a stained lab slide. The colours match the table.
  • Residents
  • Travelling bacteria
  • Viruses
  • Parasites and fungi

Start here: these are just tiny living things

  • Your body is home to trillions of bacteria, viruses and fungi. Most are good neighbours. You need many of them.
  • Germs move between people in different ways. Cold viruses use the air. Stomach bugs use food. Some germs only survive in warm, wet body tissue, so they need close contact to move. Sex is very close contact.
  • That is all an STI is. It is biology. It says nothing about whether a person is clean, careful or good.
  • It is also common. More than a million curable STIs are picked up around the world every day, and most cause no symptoms.

Two kinds of trouble

Natural does not always mean harmless. It helps to split the germs into two groups.

Residents in the wrong place

Germs that already live on you or in you. Trouble starts when they overgrow, or end up somewhere they do not belong.

Examples
Yeast. The bacteria behind BV. Ureaplasma. Gut bacteria that reach a bladder.
The fix
Restore the balance. Treatment is short, and sometimes not needed at all.

Travellers

Germs that are not part of a healthy body anywhere. They live only in humans and survive by moving from one person to the next.

Examples
Chlamydia. Gonorrhea. Syphilis. HIV. Hepatitis B. Trich.
The fix
A test, the right medicine, and telling partners. Waiting is what makes them dangerous.

Herpes and HPV sit in between. They are travellers, but so common that they are close to a normal part of adult life: about 64 in 100 people under 50 carry herpes type 1, and nearly everyone who has sex meets HPV unless vaccinated.

A common mix-up. "It is all natural stuff, just in the wrong place" is true for the first group only. For travellers the germ is just as natural, but there is no right place for it in your body. They are real infections and they need real treatment.

How to read the table

  • The five routes. Kiss is mouth to mouth. Oral is mouth on genitals or anus. Vaginal and anal mean penetration. Skin is touching without penetration, including fingers and shared toys.
  • Chance per act means one act of vaginal sex, without a condom, with a partner who has the infection and is not being treated. "Her" is the partner with a vagina. "Him" is the partner with a penis.
  • There is no single number for kissing, oral and penetration combined. Nobody has measured that. The figures are for penetration, where the data are. Oral sex is usually lower. Kissing is lower again, except for herpes, glandular fever, CMV and mpox.
  • Each number carries a tag. "Measured in couples" was counted in real people. "Model estimate" was calculated from population data. "Per partner" is the share of partners infected over a relationship. Where the table says there is no good number, there is none.
  • Small chances add up. A 1-in-5 chance per act becomes about 3-in-5 after four acts.
  • Your real risk is usually lower. These figures assume the partner has the infection. If you do not know, multiply by the chance that they do.
  • ☠️ Can be fatal. This mark sits on infections that can kill an otherwise healthy adult if nothing is done: through organ failure, cancer or a collapsed immune system. All of them can be prevented, and most can be cured or kept under control when caught early. Infections without the mark can still be dangerous for a newborn or for someone with a weak immune system. The last column says when.
  • Treatments follow current US CDC guidance. Other countries differ. The right drug and dose change with pregnancy, allergies, the part of the body infected and local drug resistance. A clinician decides; this page explains.

The table: 28 entries, from very common to very rare

Scientists know of more than 30 germs that can pass during sex. These are the ones that matter in practice, plus three residents that are often mistaken for STIs.

Show
Only

Sexually transmitted infections: routes, chance per act, treatment and what happens untreated
Infection How it spreads Chance per act no condom, partner has it Treatment and how long If left untreated what happens, and how fast

Rarer still: Ebola virus can stay in semen for months after recovery, and meningococcus, a throat bacterium, occasionally infects the urethra after oral sex.

STI or STD?

  • Infection means the germ is in your body. Disease means it is causing damage or symptoms.
  • Most STIs never become a disease. They stay silent, and they are cleared or cured first. That is why health agencies now say STI.
  • "Disease" is not wrong. It is the later chapter. Pelvic inflammatory disease, AIDS and cervical cancer are diseases caused by infections left untreated.
  • One line to remember: every STD started as an STI, but most STIs never become an STD.
  • The practical point: do not wait for symptoms. The silent infection stage is the stage to catch.

How to protect yourself

Before sex

  • Get vaccinated: HPV, hepatitis B, hepatitis A. Mpox vaccine if you are at risk.
  • Test before a new partner, and at least once a year if you have new or several partners. Feeling fine proves nothing.
  • If HIV is a realistic risk, ask about PrEP: a daily tablet, or an injection every two or six months.

During sex

  • Use condoms for vaginal and anal sex. They work best against germs carried in fluids: HIV, gonorrhea, chlamydia, trich, hepatitis B.
  • They only partly cover germs that pass by skin (herpes, HPV, syphilis, mpox) and do nothing against lice or scabies.
  • Condoms or dental dams lower the risk in oral sex.
  • Skip sex when either of you has a sore, a rash, unusual discharge, or is in the middle of treatment.

After sex

  • Possible HIV exposure: emergency medicine (PEP) works if started within 72 hours. Go the same day.
  • Doxy-PEP: one 200 mg dose of doxycycline within 72 hours cut syphilis and chlamydia by more than 70% and gonorrhea by about half in trials. The US recommends it for gay and bisexual men and transgender women with a recent STI. Since 2026, WHO says it may be offered to men who have sex with men and to transgender women. Ask whether it fits you.
  • Test at the right time. Tests need time to turn positive: about 2 weeks for chlamydia and gonorrhea, up to 3 months for syphilis and HIV.
  • If positive: take all the medicine, tell recent partners, wait 7 days after treatment before sex, and retest after 3 months.

What does not protect you

  • Washing or douching afterwards. Douching raises the risk of BV.
  • Peeing after sex. Good for bladder infections, no proven effect on STIs.
  • The contraceptive pill, an IUD, or pulling out.
  • A partner who looks healthy or says they feel fine.

Sources

  1. WHO. Sexually transmitted infections, fact sheet
  2. CDC. STI Treatment Guidelines, 2021
  3. CDC. HIV risk and prevention estimates
  4. FDA. Two oral therapies approved for gonorrhea, December 2025
  5. CDC. Doxycycline post-exposure prophylaxis guidelines, 2024
  6. WHO. Guideline on doxycycline post-exposure prophylaxis, 2026
  7. WHO. Herpes simplex virus, fact sheet
  8. WHO. Hepatitis B, fact sheet
  9. WHO. Hepatitis C, fact sheet
  10. NIH. The stages of HIV infection
  11. CDC archive. STDs and infertility
  12. Medscape. Gonorrhea overview: per-act transmission
  13. Per-partnership transmission probabilities for chlamydia (2021)
  14. Infection risk in sexual contacts of syphilis: meta-analysis (2022)
  15. Per-act HSV-2 transmission risk and condom use (2016)
  16. Modelling the sexual transmissibility of HPV (2006)
  17. Trichomonas infection rates among sexual partners (review)
  18. ACOG. Partner treatment for recurrent BV, October 2025
  19. CDC. Clinical overview of TMVII
  20. CDC. Tecovirimat for mpox
  21. Gilead. FDA approval of twice-yearly lenacapavir for HIV prevention, June 2025